Overview
Using electronic health record (EHR) data and other real-world data (RWD) sources for clinical research holds tremendous promise.
CTTI first worked in this area began with the Mini-Sentinel pilot project, when it partnered with FDA, the Harvard Pilgrim Health Care Institute, and many of the nation’s largest insurers and health systems to assess the feasibility of using the Sentinel System to conduct clinical trials. The results indicated that most participating health plans have considerable and relevant experience to use the resources created by the pilot project to conduct randomized trials.
As follow on, CTTI collaborated on IMPACT-Afib, the first trial to use the FDA-Catalyst System network of electronic health data from several national health plan data partners. This study is foundational to future clinical trials, showing that a decentralized database of claims data can be used to conduct successful research.
Solutions
Search AllRecommendation Summary
Recommendations
Resources
Related Items
- Lipid-lowering Treatment Among Older Patients with Atherosclerotic Cardiovascular Disease
- Investigators from Multiple U.S. Organizations Collaborate on First Embedded Pragmatic Clinical Trial Using National Health Plans’ Data
- FDA Catalyst–using FDA’s Sentinel Initiative for large scale pragmatic randomized trials
- Sentinel IMPACT-AFib: Transforming Pragmatic Clinical Trials Using a Nationwide Distributed Claims Database
- Participant Summary: IMPACT-AF: Formative Research Summary
- Developing Approaches to Conducting Randomized Trials in the Mini-Sentinel Environment
- Mini-Sentinel and Clinical Trials Transformation Initiative: Developing approaches to conducting randomized trials using the mini-sentinel distributed database
- Uses of Electronic Health Data to Support Clinical Trials
News
- CTTI Publication Investigates Use of Preventive Statins among Older Patients with Cardiovascular DiseaseA new CTTI publication, published in the Journal of the American Geriatrics Society, investigates the use of preventive, high-intensity statins among patients 75 and older diagnosed with atherosclerotic cardiovascular disease ...